How menopause affects oral health, and what we can do about it

被引：40

作者：

Buencamino, Maria Clarinda A. ^{[1
]}

Palomo, Leena ^{[2
]}

Thacker, Holly L. ^{[3
,4
]}

机构：

[1] Cleveland Clin, Internal Diagnost Dept, Womens Hlth Inst, Cleveland, OH 44195 USA

[2] Case Western Reserve Univ, Sch Dent Med, Cleveland, OH 44106 USA

[3] Cleveland Clin, Ctr Specialized Womens Hlth, Womens Hlth Inst, Cleveland, OH 44195 USA

[4] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2009年 / 76卷 / 08期

关键词：

BONE-MINERAL DENSITY; ESTROGEN REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; PERIODONTAL-DISEASE; SKELETAL BONE; RANDOMIZED-TRIAL; ZOLEDRONIC ACID; TOOTH LOSS; OSTEONECROSIS; ALVEOLAR;

D O I：

10.3949/ccjm.76a.08095

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

After menopause, women become more susceptible to periodontal disease. We believe the problem is due in large part to estrogen deficiency with resulting bone loss and inflammatory processes. Osteoporosis and periodontal disease are best diagnosed early so that treatment can be started sooner and fractures and tooth loss can be prevented.

引用

页码：467 / 475

页数：9

共 53 条

[1] American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws [J].

不详 .

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2007, 65 (03) :369-376

[2] Destructive periodontal disease in adults 30 years of age and older in the United states, 1988-1994 [J].

Albandar, JM ;

Brunelle, JA ;

Kingman, A .

JOURNAL OF PERIODONTOLOGY, 1999, 70 (01) :13-29

[3]

*AM DENT ASS COUNC, 2006, J AM DENT ASSOC, V137, P1144

[4]

American Dental Association Council on Access Prevention and Interprofessional Relations, 2006, WOM OR HLTH ISS

[5] Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function [J].

Berenson, JR ;

Rosen, L ;

Vescio, R ;

Lau, HS ;

Woo, M ;

Sioufi, A ;

Kowalski, O ;

Knight, RD ;

Seaman, JJ .

JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (04) :285-290

[6] Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].

Black, DM ;

Cummings, SR ;

Karpf, DB ;

Cauley, JA ;

Thompson, DE ;

Nevitt, MC ;

Bauer, DC ;

Genant, HK ;

Haskell, WL ;

Marcus, R ;

Ott, SM ;

Torner, JC ;

Quandt, SA ;

Reiss, TF ;

Ensrud, KE .

LANCET, 1996, 348 (9041) :1535-1541

[7] Bacterial species in subgingival plaque and oral bone loss in postmenopausal women [J].

Brennan, Renee M. ;

Genco, Robert J. ;

Wilding, Gregory E. ;

Hovey, Kathleen M. ;

Trevisan, Maurizio ;

Wactawski-Wende, Jean .

JOURNAL OF PERIODONTOLOGY, 2007, 78 (06) :1051-1061

[8] Bisphosphonates and osteonecrosis of the jaw: Innocent association or significant risk? [J].

Carey, John J. ;

Palomo, Leena .

CLEVELAND CLINIC JOURNAL OF MEDICINE, 2008, 75 (12) :871-879

[9] Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis [J].

Chesnut, CH ;

Skag, A ;

Christiansen, C ;

Recker, R ;

Stakkestad, JA ;

Hoiseth, A ;

Felsenberg, D ;

Huss, H ;

Gilbride, J ;

Schimmer, RC ;

Delmas, PD .

JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (08) :1241-1249

[10] Alveolar and postcranial bone density in postmenopausal women receiving hormone/estrogen replacement therapy - A randomized, double-blind, placebo-controlled trial [J].

Civitelli, R ;

Pilgram, TK ;

Dotson, M ;

Muckerman, J ;

Lewandowski, N ;

Armamento-Villareal, R ;

Yokoyama-Crothers, N ;

Kardaris, EE ;

Hauser, J ;

Cohen, S ;

Hildebolt, CF .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (12) :1409-1415

← 1 2 3 4 5 6 →